BlackRock Fund Advisors’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.95M Buy
72,896
+10,799
+17% +$404K ﹤0.01% 3086
2016
Q3
$2.77M Buy
62,097
+2,557
+4% +$109K ﹤0.01% 3084
2016
Q2
$2.4M Buy
59,540
+54,123
+999% +$2.52M ﹤0.01% 3145
2016
Q1
$252K Sell
5,417
-423
-7% -$17.9K ﹤0.01% 3390
2015
Q4
$244K Buy
5,840
+183
+3% +$7.67K ﹤0.01% 3455
2015
Q3
$221K Sell
5,657
-150
-3% -$7.01K ﹤0.01% 3431
2015
Q2
$293K Sell
5,807
-86
-1% -$4.41K ﹤0.01% 3376
2015
Q1
$340K Sell
5,893
-400
-6% -$16.7K ﹤0.01% 3347
2014
Q4
$230K Buy
6,293
+1,184
+23% +$34.9K ﹤0.01% 3451
2014
Q3
$161K Sell
5,109
-372
-7% -$9.88K ﹤0.01% 3541
2014
Q2
$141K Sell
5,481
-48,504
-90% -$1.28M ﹤0.01% 3576
2014
Q1
$1.6M Buy
53,985
+5,602
+12% +$218K ﹤0.01% 3155
2013
Q4
$1.91M Buy
48,383
+568
+1% +$21.9K ﹤0.01% 3147
2013
Q3
$5.03M Buy
47,815
+11,180
+31% +$1.37M ﹤0.01% 2811
2013
Q2
$4.73M Buy
+36,635
New +$5.4M ﹤0.01% 2720

Other funds holding FBIO

BlackRock Fund Advisors's FBIO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Fortress Biotech (FBIO) stake by 17% in Q4 2016, buying an estimated $404K and bringing the position to 72,896 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

BlackRock Fund Advisors first reported a position in FBIO in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.03M in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q4 2016.

  • BlackRock Fund Advisors held 72,896 shares of Fortress Biotech worth $2.95M as of Q4 2016.
  • BlackRock Fund Advisors bought 10,799 Fortress Biotech shares in Q4 2016, an estimated $404K.
  • Fortress Biotech made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3086 holding.
  • BlackRock Fund Advisors first reported a position in Fortress Biotech in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Fortress Biotech position peaked at $5.03M in Q3 2013.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.